Biotech Stocks
Cytokinetics brings patent suit against Bristol Myers Squibb, escalating rivalry
Endpoints News
1h ago
Cytokinetics and Bristol Myers Squibb are fierce market rivals. Now they’re also rivals in court. Cytokinetics filed a lawsuit against Bristol Myers on Wednesday, seeking to invalidate a recently granted patent protecting ...
Discussion
Sign in to join the discussion. Comments loading…